Article
Molecular subtypes and precision treatment of triple-negative breast cancer
1 Apr 2020
Abstract excerpt
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype. Despite the progress made in precision treatment of cancer patients, targeted treatment is still at its early stage in TNBC, and chemotherapy remains the standard treatment. With the advances in next generation sequencing technology, genomic and transcriptomic analyses have provided deeper insight into the inter-tumoral...
Topics
Join the communities discussing this publication.